Literature DB >> 19276086

Intracellular trafficking of presenilin 1 is regulated by beta-amyloid precursor protein and phospholipase D1.

Yun Liu1, Yun-Wu Zhang, Xin Wang, Han Zhang, Xiaoqing You, Francesca-Fang Liao, Huaxi Xu.   

Abstract

Excessive accumulation of beta-amyloid peptides in the brain is a major cause for the pathogenesis of Alzheimer disease. beta-Amyloid is derived from beta-amyloid precursor protein (APP) through sequential cleavages by beta- and gamma-secretases, whose enzymatic activities are tightly controlled by subcellular localization. Delineation of how intracellular trafficking of these secretases and APP is regulated is important for understanding Alzheimer disease pathogenesis. Although APP trafficking is regulated by multiple factors including presenilin 1 (PS1), a major component of the gamma-secretase complex, and phospholipase D1 (PLD1), a phospholipid-modifying enzyme, regulation of intracellular trafficking of PS1/gamma-secretase and beta-secretase is less clear. Here we demonstrate that APP can reciprocally regulate PS1 trafficking; APP deficiency results in faster transport of PS1 from the trans-Golgi network to the cell surface and increased steady state levels of PS1 at the cell surface, which can be reversed by restoring APP levels. Restoration of APP in APP-deficient cells also reduces steady state levels of other gamma-secretase components (nicastrin, APH-1, and PEN-2) and the cleavage of Notch by PS1/gamma-secretase that is more highly correlated with cell surface levels of PS1 than with APP overexpression levels, supporting the notion that Notch is mainly cleaved at the cell surface. In contrast, intracellular trafficking of beta-secretase (BACE1) is not regulated by APP. Moreover, we find that PLD1 also regulates PS1 trafficking and that PLD1 overexpression promotes cell surface accumulation of PS1 in an APP-independent manner. Our results clearly elucidate a physiological function of APP in regulating protein trafficking and suggest that intracellular trafficking of PS1/gamma-secretase is regulated by multiple factors, including APP and PLD1.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19276086      PMCID: PMC2673283          DOI: 10.1074/jbc.M808497200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  79 in total

1.  Kinesin-mediated axonal transport of a membrane compartment containing beta-secretase and presenilin-1 requires APP.

Authors:  A Kamal; A Almenar-Queralt; J F LeBlanc; E A Roberts; L S Goldstein
Journal:  Nature       Date:  2001-12-06       Impact factor: 49.962

2.  Purification and cloning of amyloid precursor protein beta-secretase from human brain.

Authors:  S Sinha; J P Anderson; R Barbour; G S Basi; R Caccavello; D Davis; M Doan; H F Dovey; N Frigon; J Hong; K Jacobson-Croak; N Jewett; P Keim; J Knops; I Lieberburg; M Power; H Tan; G Tatsuno; J Tung; D Schenk; P Seubert; S M Suomensaari; S Wang; D Walker; J Zhao; L McConlogue; V John
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

3.  Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.

Authors:  Ahmad Salehi; Jean-Dominique Delcroix; Pavel V Belichenko; Ke Zhan; Chengbiao Wu; Janice S Valletta; Ryoko Takimoto-Kimura; Alexander M Kleschevnikov; Kumar Sambamurti; Peter P Chung; Weiming Xia; Angela Villar; William A Campbell; Laura Shapiro Kulnane; Ralph A Nixon; Bruce T Lamb; Charles J Epstein; Gorazd B Stokin; Lawrence S B Goldstein; William C Mobley
Journal:  Neuron       Date:  2006-07-06       Impact factor: 17.173

4.  Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain.

Authors:  K Furukawa; B L Sopher; R E Rydel; J G Begley; D G Pham; G M Martin; M Fox; M P Mattson
Journal:  J Neurochem       Date:  1996-11       Impact factor: 5.372

5.  Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides.

Authors:  T Hartmann; S C Bieger; B Brühl; P J Tienari; N Ida; D Allsop; G W Roberts; C L Masters; C G Dotti; K Unsicker; K Beyreuther
Journal:  Nat Med       Date:  1997-09       Impact factor: 53.440

6.  Phospholipase D1 corrects impaired betaAPP trafficking and neurite outgrowth in familial Alzheimer's disease-linked presenilin-1 mutant neurons.

Authors:  Dongming Cai; Minghao Zhong; Runsheng Wang; William J Netzer; Dennis Shields; Hui Zheng; Sangram S Sisodia; David A Foster; Fred S Gorelick; Huaxi Xu; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-31       Impact factor: 11.205

7.  Human BACE forms dimers and colocalizes with APP.

Authors:  Ariane Schmechel; Markus Strauss; Andrea Schlicksupp; Rüdiger Pipkorn; Christian Haass; Thomas A Bayer; Gerd Multhaup
Journal:  J Biol Chem       Date:  2004-07-09       Impact factor: 5.157

8.  Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells.

Authors:  D M Kovacs; H J Fausett; K J Page; T W Kim; R D Moir; D E Merriam; R D Hollister; O G Hallmark; R Mancini; K M Felsenstein; B T Hyman; R E Tanzi; W Wasco
Journal:  Nat Med       Date:  1996-02       Impact factor: 53.440

9.  Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity.

Authors:  Giuseppina Tesco; Young Ho Koh; Eugene L Kang; Andrew N Cameron; Shinjita Das; Miguel Sena-Esteves; Mikko Hiltunen; Shao-Hua Yang; Zhenyu Zhong; Yong Shen; James W Simpkins; Rudolph E Tanzi
Journal:  Neuron       Date:  2007-06-07       Impact factor: 17.173

10.  beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms.

Authors:  C Haass; A Y Hung; M G Schlossmacher; D B Teplow; D J Selkoe
Journal:  J Biol Chem       Date:  1993-02-15       Impact factor: 5.157

View more
  21 in total

Review 1.  Cellular mechanisms of γ-secretase substrate selection, processing and toxicity.

Authors:  Gael Barthet; Anastasios Georgakopoulos; Nikolaos K Robakis
Journal:  Prog Neurobiol       Date:  2012-05-20       Impact factor: 11.685

2.  Alzheimer amyloid beta inhibition of Eg5/kinesin 5 reduces neurotrophin and/or transmitter receptor function.

Authors:  Csilla Ari; Sergiy I Borysov; Jiashin Wu; Jaya Padmanabhan; Huntington Potter
Journal:  Neurobiol Aging       Date:  2014-02-10       Impact factor: 4.673

3.  SNX27 Deletion Causes Hydrocephalus by Impairing Ependymal Cell Differentiation and Ciliogenesis.

Authors:  Xin Wang; Ying Zhou; Jian Wang; I-Chu Tseng; Timothy Huang; Yingjun Zhao; Qiuyang Zheng; Yue Gao; Hong Luo; Xian Zhang; Guojun Bu; Wanjin Hong; Huaxi Xu
Journal:  J Neurosci       Date:  2016-12-14       Impact factor: 6.167

4.  Novel susceptibility loci for Alzheimer's disease.

Authors:  Christiane Reitz
Journal:  Future Neurol       Date:  2015-12

Review 5.  Linking lipids to Alzheimer's disease: cholesterol and beyond.

Authors:  Gilbert Di Paolo; Tae-Wan Kim
Journal:  Nat Rev Neurosci       Date:  2011-03-30       Impact factor: 34.870

6.  The Coffin-Lowry syndrome-associated protein RSK2 regulates neurite outgrowth through phosphorylation of phospholipase D1 (PLD1) and synthesis of phosphatidic acid.

Authors:  Mohamed-Raafet Ammar; Yann Humeau; André Hanauer; Bernard Nieswandt; Marie-France Bader; Nicolas Vitale
Journal:  J Neurosci       Date:  2013-12-11       Impact factor: 6.167

Review 7.  Phospholipase D in brain function and Alzheimer's disease.

Authors:  Tiago Gil Oliveira; Gilbert Di Paolo
Journal:  Biochim Biophys Acta       Date:  2010-04-23

8.  Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits.

Authors:  Tiago Gil Oliveira; Robin B Chan; Huasong Tian; Mikael Laredo; Guanghou Shui; Agnieszka Staniszewski; Hong Zhang; Lili Wang; Tae-Wan Kim; Karen E Duff; Markus R Wenk; Ottavio Arancio; Gilbert Di Paolo
Journal:  J Neurosci       Date:  2010-12-08       Impact factor: 6.167

Review 9.  Golgi defects enhance APP amyloidogenic processing in Alzheimer's disease.

Authors:  Gunjan Joshi; Yanzhuang Wang
Journal:  Bioessays       Date:  2014-12-28       Impact factor: 4.345

Review 10.  Mammalian phospholipase D: Function, and therapeutics.

Authors:  M I McDermott; Y Wang; M J O Wakelam; V A Bankaitis
Journal:  Prog Lipid Res       Date:  2019-12-09       Impact factor: 16.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.